儿童软组织肿瘤大口径真空吸活检:安全性和有效性的5年回顾性分析。

IF 2.3 3区 医学 Q2 HEMATOLOGY
Abhinav R Balu, Shankar Rajeswaran, Nitin R Wadhwani, Ian Gelarden, Elizabeth Sokol, Joseph R Ness, Darshan E Variyam, Timothy Lautz, Joe B Baker
{"title":"儿童软组织肿瘤大口径真空吸活检:安全性和有效性的5年回顾性分析。","authors":"Abhinav R Balu, Shankar Rajeswaran, Nitin R Wadhwani, Ian Gelarden, Elizabeth Sokol, Joseph R Ness, Darshan E Variyam, Timothy Lautz, Joe B Baker","doi":"10.1002/pbc.32037","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Percutaneous large-bore vacuum suction biopsy (LBVSB) is an innovative alternative to open surgical biopsy and minimally invasive image-guided percutaneous core needle biopsy (PCNB) for pediatric soft tissue tumors. This study reviews our experience using this modality.</p><p><strong>Methods: </strong>A retrospective review of all children undergoing LBVSB between 2019 and 2025 was performed. Operative notes, pathology reports, and clinical follow-ups were analyzed to determine tissue adequacy and diagnosis/prognosis.</p><p><strong>Results: </strong>Fifty-five children underwent a total of 59 ultrasound-guided LBVSBs. The average age of patients was 10.5 years, but ranged from 4 months to 20 years. Biopsy was performed most often with a 10 g needle (56% of cases). The median number of samples was six (interquartile range [IQR]: 4-8), and individual core sizes ranged from 0.2 to 2.7 cm, with a median diameter of 0.3 cm (IQR: 0.2-0.4). Pathologic evaluation of the biopsy specimens accurately confirmed the final diagnosis in 54/55 cases (98% accuracy). Repeat surgical biopsy was necessary for two patients, one to more accurately characterize the tumor (Hodgkin lymphoma), and another due to persistent nodal swelling following a diagnostic biopsy (lymphoid tissue with fibrosis). Tissue samples were adequate for obtaining immunohistochemistry and molecular fusion transcripts in all cases where these were deemed necessary to make the final diagnosis. The median procedure time was 24 min (IQR: 20-30.5 min). There were two hemorrhagic complications directly associated with the biopsy procedures, and one complication associated with general anesthesia administration.</p><p><strong>Conclusion: </strong>Our experience demonstrates that image-guided percutaneous LBVSB is an accurate and efficient way to biopsy pediatric soft tissue tumors and seems to be quite safe based on our small cohort. LBVSB samples were adequate in all our patients, allowing for immunohistochemistry and fusion analysis when necessary. There were only two complications directly related to the procedure, and a repeat biopsy was only required in two cases. LBVSB can be considered as an initial diagnostic tool for certain pediatric soft tissue tumors.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32037"},"PeriodicalIF":2.3000,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Large-Bore Vacuum Suction Biopsy of Pediatric Soft Tissue Tumors: A 5-Year Retrospective Analysis of Safety and Effectiveness.\",\"authors\":\"Abhinav R Balu, Shankar Rajeswaran, Nitin R Wadhwani, Ian Gelarden, Elizabeth Sokol, Joseph R Ness, Darshan E Variyam, Timothy Lautz, Joe B Baker\",\"doi\":\"10.1002/pbc.32037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Percutaneous large-bore vacuum suction biopsy (LBVSB) is an innovative alternative to open surgical biopsy and minimally invasive image-guided percutaneous core needle biopsy (PCNB) for pediatric soft tissue tumors. This study reviews our experience using this modality.</p><p><strong>Methods: </strong>A retrospective review of all children undergoing LBVSB between 2019 and 2025 was performed. Operative notes, pathology reports, and clinical follow-ups were analyzed to determine tissue adequacy and diagnosis/prognosis.</p><p><strong>Results: </strong>Fifty-five children underwent a total of 59 ultrasound-guided LBVSBs. The average age of patients was 10.5 years, but ranged from 4 months to 20 years. Biopsy was performed most often with a 10 g needle (56% of cases). The median number of samples was six (interquartile range [IQR]: 4-8), and individual core sizes ranged from 0.2 to 2.7 cm, with a median diameter of 0.3 cm (IQR: 0.2-0.4). Pathologic evaluation of the biopsy specimens accurately confirmed the final diagnosis in 54/55 cases (98% accuracy). Repeat surgical biopsy was necessary for two patients, one to more accurately characterize the tumor (Hodgkin lymphoma), and another due to persistent nodal swelling following a diagnostic biopsy (lymphoid tissue with fibrosis). Tissue samples were adequate for obtaining immunohistochemistry and molecular fusion transcripts in all cases where these were deemed necessary to make the final diagnosis. The median procedure time was 24 min (IQR: 20-30.5 min). There were two hemorrhagic complications directly associated with the biopsy procedures, and one complication associated with general anesthesia administration.</p><p><strong>Conclusion: </strong>Our experience demonstrates that image-guided percutaneous LBVSB is an accurate and efficient way to biopsy pediatric soft tissue tumors and seems to be quite safe based on our small cohort. LBVSB samples were adequate in all our patients, allowing for immunohistochemistry and fusion analysis when necessary. There were only two complications directly related to the procedure, and a repeat biopsy was only required in two cases. LBVSB can be considered as an initial diagnostic tool for certain pediatric soft tissue tumors.</p>\",\"PeriodicalId\":19822,\"journal\":{\"name\":\"Pediatric Blood & Cancer\",\"volume\":\" \",\"pages\":\"e32037\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-09-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Blood & Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/pbc.32037\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pbc.32037","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

简介:经皮大口径真空吸活检(LBVSB)是一种创新的替代开放式手术活检和微创图像引导下经皮核针活检(PCNB)的儿科软组织肿瘤。本研究回顾了我们使用这种模式的经验。方法:对2019年至2025年间所有接受LBVSB的儿童进行回顾性分析。分析手术记录、病理报告和临床随访,以确定组织充分性和诊断/预后。结果:55例患儿共行59例超声引导下LBVSBs。患者平均年龄10.5岁,年龄从4个月到20岁不等。活检最常用10g针(56%的病例)。样本中位数为6个(四分位数间距[IQR]: 4-8),单个核心尺寸范围为0.2 ~ 2.7 cm,中位数直径为0.3 cm (IQR: 0.2 ~ 0.4)。54/55例活检标本的病理评估准确地证实了最终诊断(准确率98%)。有两名患者需要重复手术活检,一名是为了更准确地描述肿瘤(霍奇金淋巴瘤),另一名是由于诊断活检后持续的淋巴结肿胀(淋巴组织伴纤维化)。在所有病例中,组织样本足以获得免疫组织化学和分子融合转录本,这些被认为是做出最终诊断所必需的。中位手术时间为24 min (IQR: 20-30.5 min)。有两种出血性并发症与活检直接相关,一种并发症与全身麻醉有关。结论:我们的经验表明,图像引导下经皮LBVSB是一种准确、有效的儿科软组织肿瘤活检方法,根据我们的小队列研究,它似乎是相当安全的。我们所有患者的LBVSB样本都足够,必要时可以进行免疫组织化学和融合分析。只有两个并发症与手术直接相关,只有两个病例需要重复活检。LBVSB可作为某些儿童软组织肿瘤的初步诊断工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Large-Bore Vacuum Suction Biopsy of Pediatric Soft Tissue Tumors: A 5-Year Retrospective Analysis of Safety and Effectiveness.

Introduction: Percutaneous large-bore vacuum suction biopsy (LBVSB) is an innovative alternative to open surgical biopsy and minimally invasive image-guided percutaneous core needle biopsy (PCNB) for pediatric soft tissue tumors. This study reviews our experience using this modality.

Methods: A retrospective review of all children undergoing LBVSB between 2019 and 2025 was performed. Operative notes, pathology reports, and clinical follow-ups were analyzed to determine tissue adequacy and diagnosis/prognosis.

Results: Fifty-five children underwent a total of 59 ultrasound-guided LBVSBs. The average age of patients was 10.5 years, but ranged from 4 months to 20 years. Biopsy was performed most often with a 10 g needle (56% of cases). The median number of samples was six (interquartile range [IQR]: 4-8), and individual core sizes ranged from 0.2 to 2.7 cm, with a median diameter of 0.3 cm (IQR: 0.2-0.4). Pathologic evaluation of the biopsy specimens accurately confirmed the final diagnosis in 54/55 cases (98% accuracy). Repeat surgical biopsy was necessary for two patients, one to more accurately characterize the tumor (Hodgkin lymphoma), and another due to persistent nodal swelling following a diagnostic biopsy (lymphoid tissue with fibrosis). Tissue samples were adequate for obtaining immunohistochemistry and molecular fusion transcripts in all cases where these were deemed necessary to make the final diagnosis. The median procedure time was 24 min (IQR: 20-30.5 min). There were two hemorrhagic complications directly associated with the biopsy procedures, and one complication associated with general anesthesia administration.

Conclusion: Our experience demonstrates that image-guided percutaneous LBVSB is an accurate and efficient way to biopsy pediatric soft tissue tumors and seems to be quite safe based on our small cohort. LBVSB samples were adequate in all our patients, allowing for immunohistochemistry and fusion analysis when necessary. There were only two complications directly related to the procedure, and a repeat biopsy was only required in two cases. LBVSB can be considered as an initial diagnostic tool for certain pediatric soft tissue tumors.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pediatric Blood & Cancer
Pediatric Blood & Cancer 医学-小儿科
CiteScore
4.90
自引率
9.40%
发文量
546
审稿时长
1.5 months
期刊介绍: Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信